Rothschild Investment LLC’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.55K | Buy |
325
+260
| +400% | +$3.64K | ﹤0.01% | 1558 |
|
|
2025
Q1 | $884 | Sell |
65
-35
| -35% | -$476 | ﹤0.01% | 2408 |
|
|
2024
Q4 | $2.04K | Sell |
100
-50
| -33% | -$1.02K | ﹤0.01% | 1789 |
|
|
2024
Q3 | $4.37K | Buy |
150
+90
| +150% | +$2.62K | ﹤0.01% | 1348 |
|
|
2024
Q2 | $1.39K | Buy |
60
+50
| +500% | +$1.16K | ﹤0.01% | 1511 |
|
|
2024
Q1 | $205 | Buy |
+10
| New | +$205 | ﹤0.01% | 1731 |
|